Medicure Inc. (CVE:MPH – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$1.14 and traded as low as C$1.04. Medicure shares last traded at C$1.18, with a volume of 5,100 shares trading hands.
Medicure Trading Up 10.2%
The firm has a market capitalization of C$13.57 million, a PE ratio of -2.00 and a beta of 0.49. The company’s 50-day simple moving average is C$1.13 and its 200 day simple moving average is C$1.14. The company has a quick ratio of 1.28, a current ratio of 1.04 and a debt-to-equity ratio of 6.34.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.
See Also
- Five stocks we like better than Medicure
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
